If participant stops receiving pembrolizumab sooner than expected and surgery cannot happen right away, participant will return to clinic within 30 days after participant's last dose of pembrolizumab and blood (about 3 tablespoons) and urine will be collected for routine tests. Participant will then complete the follow-up visits below.